Ftse Mib
32.656,83
-2,84%
DAX
18.023,40
-1,32%
S&P 500
5.415,46
-0,34%
NASDAQ
17.649,02
-0,10%
Bitcoin
66.744,19
-0,02%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rhythm Pharmaceuticals Inc (RYTM) Rhythm Pharmaceuticals Inc (RYTM) Notizie

Rhythm Pharmaceuticals Inc

RYTM
42,59
-1,78 (-4,01%)
Ultimo aggiornamento: 17:27:12
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/6/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
03/6/202422:02GLOBERhythm Pharmaceuticals Presents Patient-reported Experiences..
03/6/202414:02GLOBERhythm Pharmaceuticals Announces Participation at Upcoming..
22/5/202410:00GLOBERhythm Pharmaceuticals Receives Positive Recommendation from..
13/5/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:17EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
07/5/202422:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:10EDGAR2Form 8-K - Current report
07/5/202413:00GLOBERhythm Pharmaceuticals Reports First Quarter 2024 Financial..
06/5/202414:00GLOBERhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics..
30/4/202400:30GLOBERhythm Pharmaceuticals Announces Publication of Results from..
24/4/202422:01GLOBERhythm Pharmaceuticals to Report First Quarter 2024..
16/4/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
01/4/202414:00GLOBERhythm Pharmaceuticals Secures $150 Million in Convertible..
25/3/202413:00GLOBERhythm Pharmaceuticals Announces First Patient Dosed in..
11/3/202421:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
06/3/202422:01GLOBERhythm Pharmaceuticals Announces Participation at Upcoming..
29/2/202422:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:46EDGAR2Form 8-K - Current report
29/2/202422:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202422:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:01EDGAR2Form 8-K - Current report
22/2/202413:01GLOBERhythm Pharmaceuticals Announces Clinical Development Plan..
22/2/202413:00GLOBERhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial..
22/2/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:19EDGAR2Form 144 - Report of proposed sale of securities
08/2/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
07/2/202414:00GLOBERhythm Pharmaceuticals Announces Positive Reimbursement..
06/2/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202414:00GLOBERhythm Pharmaceuticals to Report Fourth Quarter and Full..
12/1/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
04/1/202413:15EDGAR2Form 8-K - Current report
04/1/202413:00EDGAR2Form 8-K - Current report
04/1/202413:00GLOBERhythm Pharmaceuticals and LG Chem Life Sciences Enter..
04/1/202412:58GLOBERhythm Pharmaceuticals Announces Completion of Screening for..
29/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:22EDGAR2Form 144 - Report of proposed sale of securities
18/12/202322:16EDGAR2Form 8-K - Current report
15/12/202322:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
Apertura: 44,66 Min: 42,30 Max: 45,92
Chiusura: 44,37

La tua Cronologia

NASDAQ
RYTM
Rhythm Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network